Table 2. Advantages and disadvantages of different imaging methods for monitoring of intramyocardial injections.
Method | Exemplary target | Advantages | Disadvantages |
SPECT | Cells labelled with radionuclides [16], [18] | High sensitivity, available for human use, available for large animals, assessment of graft viability, 3D mapping (anatomy) | Potentially hazardous, poor image resolution, high costs, poor availability |
MRI | Cells labelled with iron oxides [27], [28] | High resolution, avoids ionizing radiation, combination with other (functional) measurements, 3D mapping (anatomy), small and large animals | Potential signal decay in longitudinal studies, high costs, poor availability, no assessment of graft viability |
BLI | Cells labelled with Luciferase [4], [5], [6], [19] | High sensitivity, longitudinal studies, assessment of graft viability | Poor resolution, only 2D mapping (anatomy), no clinical translation, only small animals, gene transfer needed |
MFI | Fluorescent microspheres [15], [25] | Cell-free, inexpensive, fast and easy to perform, good availability, in vivo and ex vivo assessment, quantification feasible | Potential autofluorescence, only small animals, limited to preliminary studies |
BLI: Bioluminescence Imaging; MFI: Macroscopic Fluorescence Imaging; MRI: Magnetic Resonance Imaging; SPECT: Single Photon Emission Computed Tomography.